MannKind Corp. (NASDAQ: MNKD) is just about as controversial of a company as you will find today when it comes to biotech and pharma. Its recently launched Afrezza has had disappointing initial sales under its Sanofi (NYSE: SNY) pact. 726 more words
Tags » Sny
Just announced on SNY Mets Pre-Game by Gary Apple:
Dillon Gee will be placed on the disabled list due to a groin strain, Colon will start on normal rest Sunday in the season finale against the Phillies and Noah Syndergaard will be making his much anticipated New York Mets debut in Wrigley Field against the Chicago Cubs.